IBJNews

Lilly plans 200 jobs at new $440M Ireland plant

Back to TopCommentsE-mailPrintBookmark and Share

Eli Lilly and Co. plans to invest about $440 million in a new pharmaceutical plant at an existing company site in southern Ireland, Ireland’s inward investment promotional authority said Monday morning.

The new facility in Kinsale in County Cork will require as many as 200 skilled employees when fully operational, according to a statement on IDA Ireland’s website.

Indianapolis-based Lilly will begin construction on the 240,000-square-foot manufacturing facility next month and plans to have the facility operational by late 2013, according to the Belfast Telegraph.

The project will create about 300 temporary construction jobs.

Lilly already employs about 700 people at four sites in Ireland. Its first plant in the country opened in 1981.

The company opened the Kinsale campus in 2010 after announcing it would spend about $360 million on the project.

The existing Kinsale facility manufactures active ingredients in treatments for cancer and diabetes. Products are shipped from the location to finishing plants around the world, where they are converted into tablets, capsules or injectible drugs.

Lilly employs about 38,000 people worldwide and had revenue of $24.3 billion in 2011. Its stock was up 2 cents Monday morning, to $39.07 per share.
 

ADVERTISEMENT

  • Jobs
    Congratulations Eli Lilly for the creation of 200 additional jobs in Kinsale, Ireland.

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
thisissue1-092914.jpg 092914

Subscribe to IBJ
ADVERTISEMENT